摘要
目的克隆表达EC-SOD3-凋亡素融合蛋白,并检测其生物活性。方法PCR扩增出apoptin序列,与表达载体EC-SOD3-pET-28a连接后在大肠杆菌BL21(DE3)中经IPTG诱导,表达产物进行Ni2+-NTA纯化和MTT活性检测。结果表达载体pET-28a-EC-SOD3-apoptin经酶切鉴定和序列分析,证明质粒构建正确,转化E.coliBL21(DE3)后,重组蛋白获得表达,Ni2+-NTA纯化后的凋亡素融合蛋白纯度达到85%以上,经噻唑蓝(MTT)法测定具有活性。结论成功构建了表达载体pET-28a-EC-SOD3-apoptin,并在大肠杆菌中表达了EC-SOD3-凋亡素融合蛋白,纯化的蛋白质具有诱导HeLa细胞凋亡的能力。
Objective To clone and express apoptin-EC-SOD3 fusion protein and determine its bioactivity in vitro. Methods Apoptin gene was amplified by PCR and cloned into prokaryotic expression vector EC-SOD3-pET-28a. The constructed recombinant plasmid pET-28a-EC-SOD3-apoptin was transformed to E. coli BL21 (DE3) for the expression under the induction of IPTG. The expressed protein was purified by Ni^2+ -NTA affinity chromatography and its activity was identified by MTT. Results PCR analysis proved that the recombinant plasmid pET-28a-EC- SOD3-apoptin was correctly constructed. The expressed soluble fusion protein was consistent with that expected. Its purity was over 85 % after being purified with Ni^2+ -NTA agarose and the purified protein showed bioactivity by MTF assay. Conclusion The recombinant plasmid for prokaryotic expression of pET-28a-EC-SOD3-apoptin can be constructed and the apoptin-EC-SOD3 fusion protein can be expressed successfully in E. coli BL21 ( DE3 ). MTT result indicates that HeLa cells are highly sensitive to the purified apoptin-EC-SOD3.
出处
《食品与药品》
CAS
2009年第4期7-11,共5页
Food and Drug